Former President Trump has argued that he, not President Biden or Vice President Harris, is responsible for capping insulin prices at $35 a month.
The Trump administration implemented a temporary program that allowed some Medicare drug plans to voluntarily cap insulin costs. Inflation Control Law President Biden signed the IRA bill, banning fees of more than $35 per month for such plans.
Here’s a breakdown of each administration’s actions on this issue:
Trump’s remarks
During a campaign speech in North Carolina earlier this week, President Trump claimed credit for capping insulin prices at $35 a month.
“Kamala and Joe tried to take $35 of insulin for themselves, and you know who did it? I did it,” Trump said. 75 minute speech in Thomas Wolfe Auditorium In Asheville.
President Trump has previously claimed responsibility for lowering insulin prices for Medicare beneficiaries in social media posts. June Truth Social, Biden insisted he had “nothing to do with it.”
“It was me and the Trump Administration that made low-cost insulin possible for millions of Americans, not evil Joe Biden. He had nothing to do with it. It was all done long before he unfortunately took office. All he does is try to take credit for things done by others, in this case me!” the post read.
What the Trump Administration Did
Both Trump’s comments at the North Carolina rally and on Truth Social are false. The current insulin price caps were not put in place until after Biden took office.
The Trump administration created a temporary program that allows some prescription drug plans to choose whether to cover some insulin products for no more than $35 a month.
In 2020, The government Part D Senior Savings Model It falls under the jurisdiction of the Centers for Medicare & Medicaid Innovation.
Under this model, Medicare Part D prescription drug plans could voluntarily offer coverage for “at least one dosage form of each insulin product” for no more than $35 per month. According to the analysis By health policy research group KFF.
The model came into effect in 2021 and would continue until 2023., Fewer than half of Part D prescription drug plans participate each year, according to KFF.
What the Biden Administration Did
Biden made IRAs, including the insulin price cap, law for 2022, one of his administration’s signature legislative victories.
The law prohibits all Medicare Part D prescription plans from charging more than $35 a month in copayments for all covered insulin products.
IRA rules limit cost-sharing for insulin products covered under Medicare Plan B to $35 per month and prohibit deductibles from being applied to insulin under both Part D and Part B plans.
